UCSF CME 40th Annual Advances In Heart Disease 2023

YOU WILL GET THE COURSE VIA LIFETIME DOWNLOAD LINK (FAST SPEED) AFTER PAYMENT

26 MP4 + 25 PDF Files

Overview:

Our 40th annual course will again strive to present topics that highlight new evidence-based medicine findings reported within the last one to two years that impact clinical practice. These will range across a variety of cardiologic subspecialty interests including heart failure, arrhythmias, cardiac surgery, gene therapy, aortic diseases, prevention and artificial intelligence. Our faculty will include a distinguished group of visiting academicians along with outstanding teachers and clinicians from the University of California, San Francisco.

TARGET AUDIENCE
This course is intended for cardiovascular specialists, practicing cardiologists, internists, family physicians, cardiovascular and critical care nurses, and physician assistants.

Objectives:

An attendee completing this course should be able to:

• Provide the best management of coronary heart disease, hypertension, lipid disorders, diabetes, systolic and diastolic heart failure, atrial fibrillation and flutter, STEMI and non-STEMI, thromboembolic disease
• Refine considerations for atrial fibrillation, atrial flutter, and ventricular tachycardia ablation
• Apply he best considerations of percutaneous interventions for coronary heart disease
• Improve the use of anti-platelet and anti-coagulation therapy for cardiovascular diseases
• Identify risk stratification of cardiovascular disease
• Optimize management of peripheral artery disease
• Identify and treat accordingly, the differing pathophysiology of diseases and treatment options among racial and ethnic groups
• Enhance management of COVID-19 and its cardiovascular complications

Topics And Speakers:

Friday, December 8, 2023
7:00 AM Registration and Continental Breakfast
8:10 Welcome and Symposium Overview Priscilla Hsue, MD
Session: Frontiers in Cardiology: Artificial Intelligence and the Heart, Updates in Pulmonary
Hypertension and Peripheral Vascular Disease- Chair: Priscilla Hsue, MD
8:15 Artificial Intelligence and Cardiology Debate:
Sonographer vs. AI
David Ouyang, MD
8:55 Myocarditis: Where Are We in 2023? Bettina Heidecker, MD
9:35 Genetics, Artificial Intelligence and the
Heart
James Pirruccello, MD
10:15 Coffee Break
10:30 Pulmonary Hypertension – What is New in 2023 Marc Simon, MD
11:10 Peripheral Vascular Disease Updates in 2023 Eric Secemsky, MD
11:50 Elliot Rapaport Keynote Lecture:
Earning Trust: The Heart of the Matter
Julie Gerberding MD
12:40 PM Lunch (on Your Own)
Session: New Approaches to Improving Outcomes in Heart Failure, Valve Disease, Pulmonary
Embolism and Cardiac Arrest Chair: Lucas Zier, MD, MS
2:00 Interventional Approaches to Heart Failure Lucas Zier, MD, MS
2:40 Improving Outcomes in Acute Pulmonary
Embolism
Antonio Gomez, MD
3:20 Neuroprotection Strategies After Cardiac Arrest Claude Hemphill, MD
4:00 Coffee Break
4:15 Modern Role of the Ross Procedure in the
Treatment of Aortic Valve Disease
Marko Boskovski, MD, MHS, MPH
4:55 The Current State and Future Direction of
Critical Care Cardiology
Chris Barnett, MD and Connor
O’Brien, MD
5:35 Adjourn
Saturday, December 9, 2023
7:30 AM Continental Breakfast
8:05 Announcements Priscilla Hsue, MD
Session: Advances and Controversies in Electrophysiology Chair: Nora Goldschlager, MD
8:10 Debate: Older Patients with High CHADS-VASC
and Bleeding Risk Should Have Left Atrial
Appendage Closed
Tommy Dewland, MD (pro)
Adam Lee, MD (con)
8:50 Pacing for Heart Failure with Preserved Ejection
Fraction
Ram Venkateswaran, MD
9:30 Debate: Treatment for Symptomatic Atrial
Fibrillation First-line Ablation vs.
Pharmacologic Therapy
Ed Gerstenfeld, MD
Joshua Moss MD
10:10 Coffee Break
10:25 New Technologies in Pacing for Central
Sleep Apnea and Heart Failure
Byron Lee, MD
11:05 The Effect of Alcohol, Caffeine and Tobacco on
Atrial Fibrillation – Are Any Vices OK?
Gregory Marcus, MD, MAS
11:45 Lunch (on your own)
Session: Managing Heart Failure Chair: Jonathan Davis, MD, MPHS
1:30 PM Polypharmacy and Medication Costs for Guideline
Directed Medical Therapy for Patients with Heart
Failure with Reduced Ejection Fraction
Rose Pavlakos PharmD
2:10 Remote Monitoring of Patients with Heart Failure Liviu Klein, MD, MS
2:50 Right Ventricular Heart Failure Brian Houston, MD
3:30 Coffee Break
3:45 Review of Guideline for and Management of Heart
Failure
Jonathan Davis, MD, MPHS
4:25 Approach to Multivessel Coronary Artery Disease
in Patients with Reduced Ejection Fraction
Amy Fiedler, MD and
Krishan Soni, MD, MBA
5:05 PM Adjourn
Sunday, December 10, 2023
7:30 AM Continental Breakfast
8:00 Announcements Priscilla Hsue, MD
Session: Managing Cardiovascular Risk Chair: Peter Ganz, MD
8:05 Clonal Hematopoiesis of
Indeterminate Potential (CHIP): A
Novel Cardiovascular Risk Factor
Peter Libby, MD
8:45 Lipid Management Beyond Statins: What, Why,
and Who?
Christie Ballantyne, MD
9:25 Lp(a): Why is It Important? Michelle O'Donoghue, MD, MPH
10:05 Weight Loss and Cardiovascular Risk: Current
Concepts
Sarah Kim, MD
10:45 Making Sense of Popular Diets: Alignment with
AHA 2021 Dietary Guidance
Christopher Gardner, PhD
11:25 Adjourn